Allarity Therapeutics Ownership 2024 | Who Owns Allarity Therapeutics Now?
Institutional Ownership
19.14%
Insider Ownership
12.32%
Retail Ownership
68.54%
Institutional Holders
10.00
Allarity Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.50% | 0.00% | 1,364 | 1,364 | 100.00% | 2,000 | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | - | 1,274 | 1,274 | 100.00% | 2,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 19 | 19 | 100.00% | 32,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 5 | 5 | 100.00% | 8,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 4 | 4 | 100.00% | 7,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | - | 1 | 1 | 100.00% | 2,000 | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -572 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -371 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,109 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -56 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -841 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -821 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -19 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -359 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
Allarity Therapeutics's largest institutional shareholder is TOWER RESEARCH CAPITAL LLC (TRC), holding 0.50% of the company's total share outstanding, currently valued at $2.00K. The top 10 institutional shareholders own together 0.98% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.50% | 0.00% | 1,364 | 1,364 | 100.00% | 2,000 | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | - | 1,274 | 1,274 | 100.00% | 2,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 19 | 19 | 100.00% | 32,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 5 | 5 | 100.00% | 8,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 4 | 4 | 100.00% | 7,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | - | 1 | 1 | 100.00% | 2,000 | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -572 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -371 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,109 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -56 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -841 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -821 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -19 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -359 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
The largest Allarity Therapeutics shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 1.36K shares of Allarity Therapeutics (ALLR), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.50% | 0.00% | 1,364 | 1,364 | 100.00% | 2,000 | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | - | 1,274 | 1,274 | 100.00% | 2,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 19 | 19 | 100.00% | 32,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 5 | 5 | 100.00% | 8,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 4 | 4 | 100.00% | 7,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | - | 1 | 1 | 100.00% | 2,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -19 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -56 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -359 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -371 | -100.00% | - | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -572 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -821 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -841 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,109 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Allarity Therapeutics's largest institutional buyer is TOWER RESEARCH CAPITAL LLC (TRC). The company purchased 1.36K stocks of ALLR, valued at $2.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,109 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -841 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -821 | -100.00% | - | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -572 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -371 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -359 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -56 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -19 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | - | 1 | 1 | 100.00% | 2,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 4 | 4 | 100.00% | 7,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 5 | 5 | 100.00% | 8,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 19 | 19 | 100.00% | 32,000 | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | - | 1,274 | 1,274 | 100.00% | 2,000 | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.50% | 0.00% | 1,364 | 1,364 | 100.00% | 2,000 | Mar 31, 2023 |
As of Mar 31 2023, Allarity Therapeutics's biggest institutional seller is RENAISSANCE TECHNOLOGIES LLC. The company sold -1.11K shares of ALLR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.50% | 0.00% | 1,364 | 1,364 | 100.00% | 2,000 | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.47% | - | 1,274 | 1,274 | 100.00% | 2,000 | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | 0.01% | - | 19 | 19 | 100.00% | 32,000 | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | 0.00% | - | 5 | 5 | 100.00% | 8,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.00% | - | 4 | 4 | 100.00% | 7,000 | Mar 31, 2023 |
| UBS GROUP AG | 0.00% | - | 1 | 1 | 100.00% | 2,000 | Mar 31, 2023 |
Allarity Therapeutics's largest new institutional shareholder by number of shares is TOWER RESEARCH CAPITAL LLC (TRC), purchased 1.36K shares, valued at $2.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -1,109 | -100.00% | - | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -841 | -100.00% | - | Mar 31, 2023 |
| MORGAN STANLEY | - | - | - | -821 | -100.00% | - | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -572 | -100.00% | - | Mar 31, 2023 |
| STATE STREET CORP | - | - | - | -371 | -100.00% | - | Mar 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -359 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -56 | -100.00% | - | Mar 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -19 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2 | -100.00% | - | Mar 31, 2023 |
Allarity Therapeutics's largest sold out institutional shareholder by shares sold is RENAISSANCE TECHNOLOGIES LLC, sold -1.11K shares, valued at -, as of undefined.
Allarity Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.01% | 20,000 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 25,768 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 5,302 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,565 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 6,925 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,045 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 540 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 714 | - | - | Mar 31, 2024 |
Allarity Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 20.00K shares, compromising 0.01% of its total assets.
Allarity Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 10 | 25.00% |
| 30 Sep, 22 | 8 | - |
| 30 Jun, 22 | 8 | -11.11% |
| 31 Mar, 22 | 9 | 350.00% |
| 31 Dec, 21 | 2 | - |
As of 31 Dec 22, 10 institutions are holding Allarity Therapeutics's shares, representing an increase of 25.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 145,128 | -12.11% |
| 30 Sep, 22 | 165,125 | -28.43% |
| 30 Jun, 22 | 230,705 | -32.10% |
| 31 Mar, 22 | 339,775 | 1205.52% |
| 31 Dec, 21 | 26,026 | - |
Allarity Therapeutics (ALLR) has 145.13K shares outstanding as of 31 Dec 22, down -12.11% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | 19.14% | 4.04% |
| 30 Sep, 22 | 21.78% | 2.35% |
| 30 Jun, 22 | 30.43% | 1.52% |
| 31 Mar, 22 | 44.82% | 380.30% |
| 31 Dec, 21 | 3.43% | - |
As of 31 Dec 22, Allarity Therapeutics is held by 19.14% institutional shareholders, representing a 4.04% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 5 | 150.00% |
| 30 Sep, 22 | 2 | -33.33% |
| 30 Jun, 22 | 3 | -66.67% |
| 31 Mar, 22 | 9 | 350.00% |
| 31 Dec, 21 | 2 | - |
5 institutional shareholders have increased their position in ALLR stock as of 31 Dec 22 compared to 2 in the previous quarter (a 150.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 2 | 100.00% |
| 30 Sep, 22 | 1 | -66.67% |
| 30 Jun, 22 | 3 | - |
| 31 Mar, 22 | - | - |
| 31 Dec, 21 | - | - |
2 institutional shareholders have reduced their position in ALLR stock as of 31 Dec 22 compared to 1 in the previous quarter (a 100.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 10 | 25.00% | 145,128 | -12.11% | 19.14% | 4.04% | 5 | 150.00% | 2 | 100.00% |
| 30 Sep, 22 | 8 | - | 165,125 | -28.43% | 21.78% | 2.35% | 2 | -33.33% | 1 | -66.67% |
| 30 Jun, 22 | 8 | -11.11% | 230,705 | -32.10% | 30.43% | 1.52% | 3 | -66.67% | 3 | - |
| 31 Mar, 22 | 9 | 350.00% | 339,775 | 1205.52% | 44.82% | 380.30% | 9 | 350.00% | - | - |
| 31 Dec, 21 | 2 | - | 26,026 | - | 3.43% | - | 2 | - | - | - |
Allarity Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Allarity Therapeutics's stock was made by Carchedi Steve on Dec 22 2021, selling 70,477 shares at $12.02 per share (valued at $847.13K).
Allarity Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Allarity Therapeutics's insiders, as of Q3 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2023 | - | - | - |
As of Q3 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Allarity Therapeutics's stocks.
Allarity Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. |
| BDRX | Biodexa Pharmaceuticals Plc |
| CNSP | CNS Pharmaceuticals, Inc. |
| VIRI | Virios Therapeutics, Inc. |
| PHIO | Phio Pharmaceuticals Corp. |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| VRAX | Virax Biolabs Group Limited |
| EFTR | eFFECTOR Therapeutics, Inc. |
| IMMX | Immix Biopharma, Inc. |
| SONN | Sonnet BioTherapeutics Holdings, Inc. |
| ZURA | Zura Bio Limited |
ALLR Ownership FAQ
Who Owns Allarity Therapeutics?
Allarity Therapeutics is owned by institutional shareholders (19.14%), insiders (12.32%), and public (68.54%). The largest institutional shareholder of Allarity Therapeutics is TOWER RESEARCH CAPITAL LLC (TRC) (0.50% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.01% of total shares).
Who are the major institutional shareholders of Allarity Therapeutics?
Allarity Therapeutics's major institutional shareholders are TOWER RESEARCH CAPITAL LLC (TRC), ACADIAN ASSET MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, and MORGAN STANLEY. The top five shareholders own together 0.98% of the company's share outstanding.
How many Allarity Therapeutics shareholders are there?
As of Dec 2022, there are 10 institutional shareholders of Allarity Therapeutics.
What percentage of Allarity Therapeutics is owned by TOWER RESEARCH CAPITAL LLC (TRC)?
TOWER RESEARCH CAPITAL LLC (TRC) owns 1.36K shares of Allarity Therapeutics, representing 0.50% of the company's total shares outstanding, valued at $2K (as of Mar 2023).
What percentage of Allarity Therapeutics is owned by ACADIAN ASSET MANAGEMENT LLC?
As of Mar 2023, ACADIAN ASSET MANAGEMENT LLC holds 1.27K shares of Allarity Therapeutics (ALLR), compromising 0.47% of the company, valued at $2K.
What percentage of Allarity Therapeutics is owned by BANK OF AMERICA CORP /DE/?
BANK OF AMERICA CORP /DE/ is the third largest holder of Allarity Therapeutics. The company owns 19 of the company's shares outstanding (worth $32K).